RE: Cohort 715 Nov 2023 10:19
What a prawn.
Just for starters, whilst rare problems are important for prophylaxis, vaccines and general widely given medications they are no consideration at all for the treatment of patients who all have progressive and fatal disease.
Secondly, standard dox exhibits its cytotoxicity everywhere - joints, liver, brain (for those with one), etc. Targeting reduces the range and severity with which non-tumour tissues are affected.
Thirdly, we know targetting works.